These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9796722)

  • 1. Quantitative measurement of telomerase activity in lymphadenopathy: correlation with histologic features and human immunodeficiency virus-1 infection.
    Strovel JW; Abruzzo LV; Highsmith WE; Stamberg J
    Mod Pathol; 1998 Oct; 11(10):957-62. PubMed ID: 9796722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5'-->3' exonuclease-based real-time PCR assays for detecting the t(14;18)(q32;21): a survey of 162 malignant lymphomas and reactive specimens.
    Estalilla OC; Medeiros LJ; Manning JT; Luthra R
    Mod Pathol; 2000 Jun; 13(6):661-6. PubMed ID: 10874671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
    Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
    Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease overexpress the telomerase RNA template (hTR).
    Heine B; Hummel M; Demel G; Stein H
    J Pathol; 1999 Jun; 188(2):139-45. PubMed ID: 10398156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.
    Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; Kato H; Wright WE; Shay JW
    Cancer Res; 1997 Jun; 57(11):2100-3. PubMed ID: 9187102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid.
    Aogi K; Kitahara K; Urquidi V; Tarin D; Goodison S
    Clin Cancer Res; 1999 Oct; 5(10):2790-7. PubMed ID: 10537343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
    Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
    Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas.
    MacNamara B; Wang W; Chen Z; Hou M; Mazur J; Gruber A; Porwit-MacDonald A
    Haematologica; 2001 Apr; 86(4):386-93. PubMed ID: 11325644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
    Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
    Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
    Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
    Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity in Hodgkin's disease.
    Norrback KF; Enblad G; Erlanson M; Sundström C; Roos G
    Blood; 1998 Jul; 92(2):567-73. PubMed ID: 9657757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers.
    Itoi T; Shinohara Y; Takeda K; Takei K; Ohno H; Ohyashiki K; Yahata N; Ebihara Y; Saito T
    Gastrointest Endosc; 2000 Sep; 52(3):380-6. PubMed ID: 10968854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
    Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
    J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
    Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C
    Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.